HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 72/6/1352    most recent biolreprod.104.037143v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Related articles in Biol Reprod Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal My Folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xu, F. Articles by Stouffer, R. L. Search for Related Content PubMed PubMed Citation Articles by Xu, F. Articles by Stouffer, R. L. Agricola Articles by Xu, F. Articles by Stouffer, R. L.

Local Delivery of Angiopoietin-2 into the Preovulatory Follicle Terminates the Menstrual Cycle in Rhesus Monkeys¹

Division of Reproductive Sciences, Oregon National Primate Research Center,³ Department of Physiology and Pharmacology,⁴ Oregon Health & Science University, Portland, Oregon 97239 Department of Environmental and Biomolecular Systems,⁵ OGI School of Science & Engineering, Oregon Health & Science University, Beaverton, Oregon 97006

The angiopoietin (ANGPT)-receptor (TEK) system plays a crucial role in blood vessel formation and stability. Because the endogenous agonist ANGPT1, antagonist ANGPT2, and TEK are expressed in the primate ovary, experiments were designed to investigate their role at a critical time during tissue remodeling/ angiogenesis in the menstrual cycle (i.e., at midcycle during maturation, ovulation, and luteinization of the dominant follicle). Either vehicle, 20 µg of ANGPT1, 2 µg of ANGPT2 (low-dose), or 20 µg of ANGPT2 (high-dose) was injected directly into the preovulatory follicle of monkeys around the day (–1 to 0) of the midcycle estradiol (E₂)/LH peak. Ovaries were evaluated on Day 3 postinjection for follicle rupture, and serum samples were analyzed for levels of E₂ and progesterone. Similar to controls, ANGPT1 treatment was followed by ovulation, and elevated progesterone levels during the luteal phase. In contrast, high-dose ANGPT2 treatment prevented follicle rupture, and progesterone levels never rose above baseline in the subsequent 12 days. However, an E₂ peak typically occurred 12 days postinjection. Laparoscopy detected a preovulatory follicle on the contralateral (noninjected) ovary. Progesterone levels subsequently increased above baseline in these animals. Thus, exogenous ANGPT2 disrupted maturation of the preovulatory follicle, preventing its ovulation and conversion into the corpus luteum. ANGPT antagonism eliminated the dominant structure, thereby resetting the ovarian cycle, with selection and maturation of the next preovulatory follicle occurring in a timely manner. The data are consistent with a critical role of the ANGPT-TIE1/TEK system in the ovary, notably at the late stages of follicle maturation during the menstrual cycle.

angiogenesis, angiopoietin-1, angiopoietin-2, corpus luteum, follicle, menstrual cycle, ovary, ovulation, preovulatory follicle, rhesus monkeys

² Correspondence: Richard L. Stouffer, Division of Reproductive Sciences, Oregon National Primate Research Center, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, OR 97006. stouffri{at}ohsu.edu

Related articles in Biol Reprod:

Highlights

John Davis, John Eppig, and Mary Ann Handel
Biol Reprod 2005 72: 1289. [Full Text]  

This article has been cited by other articles:

				J. Xu, F. Xu, J. D. Hennebold, T. A. Molskness, and R. L. Stouffer Expression and Role of the Corticotropin-Releasing Hormone/Urocortin-Receptor-Binding Protein System in the Primate Corpus Luteum during the Menstrual Cycle Endocrinology, November 1, 2007; 148(11): 5385 - 5395. [Abstract] [Full Text] [PDF]